Hypoalbuminemia has previously been reported as a predictive marker of COVID-19 mortality (75), and COVID-19 patients who received albumin infusions have been shown to have reduced IL-6 and IL-2R concentrations (76). The gene discussed is IL6; the disease is COVID-19.